(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.82%.
Instil Bio's earnings in 2026 is -$75,076,000.On average, 5 Wall Street analysts forecast TIL's earnings for 2026 to be -$37,862,416, with the lowest TIL earnings forecast at -$76,034,089, and the highest TIL earnings forecast at -$7,975,604.
In 2027, TIL is forecast to generate -$56,716,309 in earnings, with the lowest earnings forecast at -$55,031,666 and the highest earnings forecast at -$58,962,499.